Cantabio Pharmaceuticals Inc.


CANTABio’s research is focused on reducing the harmful effects of biochemical stress, preventing and slowing resulting diseases through developing novel disease modifying therapeutics for neurodegeneration and metabolic conditions

Learn More

Drug Discovery Research

Cantabio strategically integrates therapeutic focus, target family biophysics, novel drug discovery technologies and expertise into innovative drug discovery approaches.

View Video

Cantabio featured as "Top 10 World Changing Technology"

Cantabio Pharmaceuticals' work on targeting intrinsically disordered proteins was highlighted as a "Top 10 World Changing Technology" by the World Economic Forum 

Read Article
Latest News Cantabio Announces Publication of Novel Study Demonstrating the Importance of the DJ-1 Protein in the Onset and Pathology of Alzheimer's and Parkinson's disease Read More